Výsledky vyhledávání - "Helga W Vermaas"

Akademický článek

Objectives and Design of BLEEDS: A Cohort Study to Identify New Risk Factors and Predictors for Major Bleeding during Treatment with Vitamin K Antagonists.

Autor: Nienke van Rein, Willem M Lijfering, Mettine H A Bos, Martien H Herruer, Helga W Vermaas, Felix J M van der Meer, Pieter H Reitsma

Publikováno v: PLoS ONE, Vol 11, Iss 12, p e0164485 (2016)

Risk scores for patients who are at high risk for major bleeding complications during treatment with vitamin K antagonists (VKAs) do not perform that well. BLEEDS was initiated to search for new biomarkers that predict bleeding in these patients.To d

Externí odkaz: https://doaj.org/article/8e4556d104514dd691ba79eb7bb4ff79

Zobrazit plný text záznamu

Akademický článek

Self‐reported therapy adherence and predictors for nonadherence in patients who switched from vitamin K antagonists to direct oral anticoagulants

Autor: Myrthe M. A. Toorop, Nienke vanRein, Melchior C. Nierman, Helga W. Vermaas, Menno V. Huisman, Felix J. M. van derMeer, Suzanne C. Cannegieter, Willem M. Lijfering

Publikováno v: Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 4, Pp 586-593 (2020)

Abstract Background Many patients who used vitamin K antagonists (VKAs) for long‐term prevention of thromboembolism are now actively switched to a direct oral anticoagulant (DOAC). Strict adherence to a DOAC is crucial for its success. However, the

Externí odkaz: https://doaj.org/article/d66244669c374611bb64e83c57f133f9

Zobrazit plný text záznamu

Self-reported therapy adherence and predictors for nonadherence in patients who switched from vitamin K antagonists to direct oral anticoagulants

Autor: Menno V. Huisman, Helga W. Vermaas, Willem M. Lijfering, Felix J. M. van der Meer, Nienke van Rein, Suzanne C. Cannegieter, Melchior C Nierman, Myrthe M A Toorop

Publikováno v: Research and practice in thrombosis and haemostasis, 4(4), 586-593. Wiley-Blackwell Publishing Ltd
Research and Practice in Thrombosis and Haemostasis, 4(4), 586-593. WILEY
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 4, Pp 586-593 (2020)
Research and Practice in Thrombosis and Haemostasis

Background Many patients who used vitamin K antagonists (VKAs) for long‐term prevention of thromboembolism are now actively switched to a direct oral anticoagulant (DOAC). Strict adherence to a DOAC is crucial for its success. However, therapy adhe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b259f122da5dbc015316d5c7214c93a4
https://doi.org/10.1002/rth2.12316

Zobrazit plný text záznamu

Switching from vitamin K antagonists to direct oral anticoagulants: treatment satisfaction and patient concerns

Autor: Menno V. Huisman, Myrthe M A Toorop, Suzanne C. Cannegieter, Nienke van Rein, Helga W. Vermaas, Willem M. Lijfering, Felix J. M. van der Meer, Melchior C Nierman

Publikováno v: Journal of Thrombosis and Haemostasis, 18(6), 1390-1397. WILEY
Journal of thrombosis and haemostasis, 18(6), 1390-1397. Wiley-Blackwell
Journal of Thrombosis and Haemostasis

Background Since direct oral anticoagulants (DOACs) have been introduced for treatment and prevention of thromboembolic diseases, patients on vitamin K antagonists (VKA) have to decide whether to remain on VKA or switch to DOAC. The goal of this stud

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::156479550726b20cd4a92b9fdaf80e79
http://hdl.handle.net/1887/3184702

Zobrazit plný text záznamu

Relationship between neighborhood socioeconomic status and venous thromboembolism: results from a population-based study

Autor: Willem M. Lijfering, Suzanne C. Cannegieter, D. Kort, F. J. M. Van Der Meer, Helga W. Vermaas, N. Wiersma, N. van Rein

Publikováno v: Journal of Thrombosis and Haemostasis, 15(12), 2352-2360
Journal of Thrombosis and Haemostasis

Essentials Literature on socioeconomic status (SES) and incidence of venous thromboembolism (VTE) is scarce. We assessed neighborhood SES with VTE risk in a population of over 1.4 million inhabitants. Higher neighborhood SES was associated with lower

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e40a23b457f73c6de71178b0255afeb
https://pubmed.ncbi.nlm.nih.gov/29027356

Zobrazit plný text záznamu

Objectives and Design of BLEEDS: A Cohort Study to Identify New Risk Factors and Predictors for Major Bleeding during Treatment with Vitamin K Antagonists

Autor: Helga W. Vermaas, Nienke van Rein, Mettine H.A. Bos, Pieter H. Reitsma, Martien H. Herruer, Felix J. M. van der Meer, Willem M. Lijfering

Publikováno v: PLoS ONE
PLoS ONE, 11(12)
PLoS ONE, Vol 11, Iss 12, p e0164485 (2016)

Background Risk scores for patients who are at high risk for major bleeding complications during treatment with vitamin K antagonists (VKAs) do not perform that well. BLEEDS was initiated to search for new biomarkers that predict bleeding in these pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3f3cd02f09f20caef185446d0b441bb
https://hdl.handle.net/1887/113185

Zobrazit plný text záznamu

Major bleeding risks of different low-molecular-weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis

Autor: Willem M. Lijfering, N. Wiersma, Joseph S. Biedermann, N. van Rein, Pieter H. Reitsma, Helga W. Vermaas, F. J. M. Van Der Meer, Marieke J. H. A. Kruip, Suzanne C. Cannegieter

Publikováno v: Journal of Thrombosis and Haemostasis, 15(7), 1386-1391
Journal of Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis, 15(7), 1386-1391. Wiley-Blackwell Publishing Ltd

_Essentials:_ - Low-molecular-weight-heparins (LMWH) kinetics differ which may result in different bleeding risks. - A cohort of 12 934 venous thrombosis patients on LMWH was followed until major bleeding. - The absolute major bleeding risk was low a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac5f6fe2f77eff9c5de993e3a2b5fa68
https://pubmed.ncbi.nlm.nih.gov/28440008

Zobrazit plný text záznamu

Clinical Outcome After Occurrence Of Vitamin K-Antagonist Related Major Bleeding Complication: A Two-Year Observational Follow-Up Study

Autor: Nakisa Khorsand, Paula F. Ypma, Shakiba Zahedin Labbaf, Reinier M. van Hest, Karina Meijer, Helga W Vermaas, Nic J. G. M. Veeger

Publikováno v: Blood, 122(21). AMER SOC HEMATOLOGY

History of major bleed during vitamin K-antagonist (VKA) therapy is an important predictor for future major bleeds. However, these patients do have an increased risk for thromboembolic events (TE) due to the underlying disease, and clinicians face a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa9a6b1b288739c2f55ddf12e512be90
https://doi.org/10.1182/blood.v122.21.2382.2382

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání